S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version
2013; Wiley; Volume: 11; Issue: 6 Linguagem: Inglês
10.1111/ddg.12044
ISSN1610-0387
AutoresAnnette Pflugfelder, Corinna Kochs, Andreas Blum, Marcus Capellaro, Johanna Christina Czeschik, Therese Dettenborn, Dorothee Dill, Edgar Dippel, Thomas Eigentler, Petra Feyer, Markus Follmann, Bernhard Frerich, Maria‐Katharina Ganten, Jan Gärtner, Ralf Gutzmer, Jessica C. Hassel, Axel Hauschild, Peter Hohenberger, Jutta Hübner, Martin Kaatz, Ulrich R. Kleeberg, Oliver Kölbl, Rolf‐Dieter Kortmann, Albrecht Krause‐Bergmann, Peter Kurschat, Ulrike Leiter, Hartmut Link, Carmen Loquai, Christoph Löser, Andréas Mackensen, Friedegund Meier, Peter Mohr, Matthias Möhrle, Dorothée Nashan, Sven N. Reske, Christian Rosé, Christian A. Sander, Imke Satzger, Meinhard Schiller, Heinz‐Peter Schlemmer, Gerhard Strittmatter, Cord Sunderkötter, L. Swoboda, Uwe Trefzer, Raymond Voltz, Dirk Vordermark, Michael Weichenthal, A. Werner, Simone Wesselmann, Ansgar Weyergraf, Wolfgang Wick, Claus Garbe, Dirk Schadendorf,
Tópico(s)Infectious Diseases and Mycology
ResumoJDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 11, Issue 6 p. 563-602 Guidelines S3-Guideline "Diagnosis, therapy and follow-up of melanoma" – short version Annette Pflugfelder, Annette Pflugfelder Department of Dermatology, University Hospital Tübingen, Germany shared first authorship,Search for more papers by this authorCorinna Kochs, Corinna Kochs Department of Dermatology, University Hospital Essen, Germany shared first authorship,Search for more papers by this authorAndreas Blum, Andreas Blum Public, Private and Teaching Practice of Dermatology, Konstanz, GermanySearch for more papers by this authorMarcus Capellaro, Marcus Capellaro Association of Dermatological Prevention, Buxtehude, GermanySearch for more papers by this authorChristina Czeschik, Christina Czeschik Department of Dermatology, University Hospital Essen, GermanySearch for more papers by this authorTherese Dettenborn, Therese Dettenborn Plastische und Ästhetische Chirurgie, Fachklinik Hornheide, GermanySearch for more papers by this authorDorothee Dill, Dorothee Dill Hautklinik Lüdenscheidt, GermanySearch for more papers by this authorEdgar Dippel, Edgar Dippel Department of Dermatology, Skin Cancer Center, Ludwigshafen Hospital, GermanySearch for more papers by this authorThomas Eigentler, Thomas Eigentler Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorPetra Feyer, Petra Feyer Clinic of radiotherapy and radiooncology, Vivantes Clinics Neukölln – Berlin, GermanySearch for more papers by this authorMarkus Follmann, Markus Follmann The German Cancer Society Berlin, GermanySearch for more papers by this authorBernhard Frerich, Bernhard Frerich Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University of Rostock, GermanySearch for more papers by this authorMaria-Katharina Ganten, Maria-Katharina Ganten German Cancer Research Center Heidelberg, Department of Radiology, Heidelberg, GermanySearch for more papers by this authorJan Gärtner, Jan Gärtner Department of Palliative Medicine, University Hospital Cologne, GermanySearch for more papers by this authorRalf Gutzmer, Ralf Gutzmer Department of Dermatology and Allergy, Hannover Medical School, GermanySearch for more papers by this authorJessica Hassel, Jessica Hassel German Cancer Research Center, Heidelberg, GermanySearch for more papers by this authorAxel Hauschild, Axel Hauschild Department of Dermatology, University of Kiel, GermanySearch for more papers by this authorPeter Hohenberger, Peter Hohenberger Div. of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, GermanySearch for more papers by this authorJutta Hübner, Jutta Hübner Johann Wolfgang Goethe University, Frankfurt am Main, GermanySearch for more papers by this authorMartin Kaatz, Martin Kaatz Department of Dermatology and Allergology, SRH Waldklinikum Gera Gmbh, GermanySearch for more papers by this authorUlrich R. Kleeberg, Ulrich R. Kleeberg Hämatologisch-onkologische Praxis Altona (HOPA), Struensee-Haus, Hamburg, GermanySearch for more papers by this authorOliver Kölbl, Oliver Kölbl Department of Radiotherapy, University Hospital Regensburg, GermanySearch for more papers by this authorRolf-Dieter Kortmann, Rolf-Dieter Kortmann Department of Radiation Therapy, University of Leipzig, GermanySearch for more papers by this authorAlbrecht Krause-Bergmann, Albrecht Krause-Bergmann Plastische und Ästhetische Chirurgie, Fachklinik Hornheide, GermanySearch for more papers by this authorPeter Kurschat, Peter Kurschat Department of Dermatology and Venereology, University Hospital of Cologne, GermanySearch for more papers by this authorUlrike Leiter, Ulrike Leiter Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorHartmut Link, Hartmut Link Medical Clinic I, Westpfalz Klinikum, Kaiserslautern, GermanySearch for more papers by this authorCarmen Loquai, Carmen Loquai Department of Dermatology, University of Mainz, GermanySearch for more papers by this authorChristoph Löser, Christoph Löser Department of Dermatology, Skin Cancer Center, Ludwigshafen Hospital, GermanySearch for more papers by this authorAndreas Mackensen, Andreas Mackensen Dept. of Internal Medicine 5 – Hematology/Oncology, University of Erlangen, GermanySearch for more papers by this authorFriedegund Meier, Friedegund Meier Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorPeter Mohr, Peter Mohr Association of Dermatological Prevention, Buxtehude, GermanySearch for more papers by this authorMatthias Möhrle, Matthias Möhrle Department of Dermatology, University Hospital Tübingen, Germany Praxisklinik Tübingen – Haut und Venen, GermanySearch for more papers by this authorDorothee Nashan, Dorothee Nashan Department of Dermatology, Klinikum Dortmund gGmbH, GermanySearch for more papers by this authorSven Reske, Sven Reske Department of Nuclear Medicine, University Clinic, Ulm, GermanySearch for more papers by this authorChristian Rose, Christian Rose Lübeck, GermanySearch for more papers by this authorChristian Sander, Christian Sander Klinik für Dermatologie und Allergologie, Asklepios Klinik St. Georg, GermanySearch for more papers by this authorImke Satzger, Imke Satzger Department of Dermatology and Allergy, Hannover Medical School, GermanySearch for more papers by this authorMeinhard Schiller, Meinhard Schiller Department of Dermatology, University Hospital of Münster, Münster, GermanySearch for more papers by this authorHeinz-Peter Schlemmer, Heinz-Peter Schlemmer German Cancer Research Center Heidelberg, Department of Radiology, Heidelberg, GermanySearch for more papers by this authorGerhard Strittmatter, Gerhard Strittmatter Department of Psychosocial Oncology, Fachklinik Hornheide, Münster, GermanySearch for more papers by this authorCord Sunderkötter, Cord Sunderkötter Department of Dermatology, University Hospital of Münster, Münster, GermanySearch for more papers by this authorLothar Swoboda, Lothar Swoboda German Society of Thoracic Surgery, Berlin, GermanySearch for more papers by this authorUwe Trefzer, Uwe Trefzer Department of Dermatology, University Hospital Charité Berlin, GermanySearch for more papers by this authorRaymond Voltz, Raymond Voltz Department of Palliative Medicine, University Hospital Cologne, GermanySearch for more papers by this authorDirk Vordermark, Dirk Vordermark Department of Radiooncology, Universitätsklinikum Halle, Halle/Saale, GermanySearch for more papers by this authorMichael Weichenthal, Michael Weichenthal Department of Dermatology, University of Kiel, GermanySearch for more papers by this authorAndreas Werner, Andreas Werner Tumor Center Rhineland Palatinate, Mainz, GermanySearch for more papers by this authorSimone Wesselmann, Simone Wesselmann The German Cancer Society Berlin, GermanySearch for more papers by this authorAnsgar J. Weyergraf, Ansgar J. Weyergraf Bad Bentheim Hospital, Department of Dermatology and Allergy, Bad Bentheim, GermanySearch for more papers by this authorWolfgang Wick, Wolfgang Wick Dep. of Neurooncology, University Clinic, Heidelberg, GermanySearch for more papers by this authorClaus Garbe, Claus Garbe Department of Dermatology, University Hospital Tübingen, Germany shared last authorshipSearch for more papers by this authorDirk Schadendorf, Dirk Schadendorf Department of Dermatology, University Hospital Essen, Germany shared last authorshipSearch for more papers by this author Annette Pflugfelder, Annette Pflugfelder Department of Dermatology, University Hospital Tübingen, Germany shared first authorship,Search for more papers by this authorCorinna Kochs, Corinna Kochs Department of Dermatology, University Hospital Essen, Germany shared first authorship,Search for more papers by this authorAndreas Blum, Andreas Blum Public, Private and Teaching Practice of Dermatology, Konstanz, GermanySearch for more papers by this authorMarcus Capellaro, Marcus Capellaro Association of Dermatological Prevention, Buxtehude, GermanySearch for more papers by this authorChristina Czeschik, Christina Czeschik Department of Dermatology, University Hospital Essen, GermanySearch for more papers by this authorTherese Dettenborn, Therese Dettenborn Plastische und Ästhetische Chirurgie, Fachklinik Hornheide, GermanySearch for more papers by this authorDorothee Dill, Dorothee Dill Hautklinik Lüdenscheidt, GermanySearch for more papers by this authorEdgar Dippel, Edgar Dippel Department of Dermatology, Skin Cancer Center, Ludwigshafen Hospital, GermanySearch for more papers by this authorThomas Eigentler, Thomas Eigentler Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorPetra Feyer, Petra Feyer Clinic of radiotherapy and radiooncology, Vivantes Clinics Neukölln – Berlin, GermanySearch for more papers by this authorMarkus Follmann, Markus Follmann The German Cancer Society Berlin, GermanySearch for more papers by this authorBernhard Frerich, Bernhard Frerich Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University of Rostock, GermanySearch for more papers by this authorMaria-Katharina Ganten, Maria-Katharina Ganten German Cancer Research Center Heidelberg, Department of Radiology, Heidelberg, GermanySearch for more papers by this authorJan Gärtner, Jan Gärtner Department of Palliative Medicine, University Hospital Cologne, GermanySearch for more papers by this authorRalf Gutzmer, Ralf Gutzmer Department of Dermatology and Allergy, Hannover Medical School, GermanySearch for more papers by this authorJessica Hassel, Jessica Hassel German Cancer Research Center, Heidelberg, GermanySearch for more papers by this authorAxel Hauschild, Axel Hauschild Department of Dermatology, University of Kiel, GermanySearch for more papers by this authorPeter Hohenberger, Peter Hohenberger Div. of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, GermanySearch for more papers by this authorJutta Hübner, Jutta Hübner Johann Wolfgang Goethe University, Frankfurt am Main, GermanySearch for more papers by this authorMartin Kaatz, Martin Kaatz Department of Dermatology and Allergology, SRH Waldklinikum Gera Gmbh, GermanySearch for more papers by this authorUlrich R. Kleeberg, Ulrich R. Kleeberg Hämatologisch-onkologische Praxis Altona (HOPA), Struensee-Haus, Hamburg, GermanySearch for more papers by this authorOliver Kölbl, Oliver Kölbl Department of Radiotherapy, University Hospital Regensburg, GermanySearch for more papers by this authorRolf-Dieter Kortmann, Rolf-Dieter Kortmann Department of Radiation Therapy, University of Leipzig, GermanySearch for more papers by this authorAlbrecht Krause-Bergmann, Albrecht Krause-Bergmann Plastische und Ästhetische Chirurgie, Fachklinik Hornheide, GermanySearch for more papers by this authorPeter Kurschat, Peter Kurschat Department of Dermatology and Venereology, University Hospital of Cologne, GermanySearch for more papers by this authorUlrike Leiter, Ulrike Leiter Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorHartmut Link, Hartmut Link Medical Clinic I, Westpfalz Klinikum, Kaiserslautern, GermanySearch for more papers by this authorCarmen Loquai, Carmen Loquai Department of Dermatology, University of Mainz, GermanySearch for more papers by this authorChristoph Löser, Christoph Löser Department of Dermatology, Skin Cancer Center, Ludwigshafen Hospital, GermanySearch for more papers by this authorAndreas Mackensen, Andreas Mackensen Dept. of Internal Medicine 5 – Hematology/Oncology, University of Erlangen, GermanySearch for more papers by this authorFriedegund Meier, Friedegund Meier Department of Dermatology, University Hospital Tübingen, GermanySearch for more papers by this authorPeter Mohr, Peter Mohr Association of Dermatological Prevention, Buxtehude, GermanySearch for more papers by this authorMatthias Möhrle, Matthias Möhrle Department of Dermatology, University Hospital Tübingen, Germany Praxisklinik Tübingen – Haut und Venen, GermanySearch for more papers by this authorDorothee Nashan, Dorothee Nashan Department of Dermatology, Klinikum Dortmund gGmbH, GermanySearch for more papers by this authorSven Reske, Sven Reske Department of Nuclear Medicine, University Clinic, Ulm, GermanySearch for more papers by this authorChristian Rose, Christian Rose Lübeck, GermanySearch for more papers by this authorChristian Sander, Christian Sander Klinik für Dermatologie und Allergologie, Asklepios Klinik St. Georg, GermanySearch for more papers by this authorImke Satzger, Imke Satzger Department of Dermatology and Allergy, Hannover Medical School, GermanySearch for more papers by this authorMeinhard Schiller, Meinhard Schiller Department of Dermatology, University Hospital of Münster, Münster, GermanySearch for more papers by this authorHeinz-Peter Schlemmer, Heinz-Peter Schlemmer German Cancer Research Center Heidelberg, Department of Radiology, Heidelberg, GermanySearch for more papers by this authorGerhard Strittmatter, Gerhard Strittmatter Department of Psychosocial Oncology, Fachklinik Hornheide, Münster, GermanySearch for more papers by this authorCord Sunderkötter, Cord Sunderkötter Department of Dermatology, University Hospital of Münster, Münster, GermanySearch for more papers by this authorLothar Swoboda, Lothar Swoboda German Society of Thoracic Surgery, Berlin, GermanySearch for more papers by this authorUwe Trefzer, Uwe Trefzer Department of Dermatology, University Hospital Charité Berlin, GermanySearch for more papers by this authorRaymond Voltz, Raymond Voltz Department of Palliative Medicine, University Hospital Cologne, GermanySearch for more papers by this authorDirk Vordermark, Dirk Vordermark Department of Radiooncology, Universitätsklinikum Halle, Halle/Saale, GermanySearch for more papers by this authorMichael Weichenthal, Michael Weichenthal Department of Dermatology, University of Kiel, GermanySearch for more papers by this authorAndreas Werner, Andreas Werner Tumor Center Rhineland Palatinate, Mainz, GermanySearch for more papers by this authorSimone Wesselmann, Simone Wesselmann The German Cancer Society Berlin, GermanySearch for more papers by this authorAnsgar J. Weyergraf, Ansgar J. Weyergraf Bad Bentheim Hospital, Department of Dermatology and Allergy, Bad Bentheim, GermanySearch for more papers by this authorWolfgang Wick, Wolfgang Wick Dep. of Neurooncology, University Clinic, Heidelberg, GermanySearch for more papers by this authorClaus Garbe, Claus Garbe Department of Dermatology, University Hospital Tübingen, Germany shared last authorshipSearch for more papers by this authorDirk Schadendorf, Dirk Schadendorf Department of Dermatology, University Hospital Essen, Germany shared last authorshipSearch for more papers by this author First published: 30 May 2013 https://doi.org/10.1111/ddg.12044Citations: 21 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Robert Koch-Institut. http://www.rki.de 2012. 2Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC, Jr., Morton DL, Ross MI, Sober AJ, Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199–206. 3Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003; 97: 1488–98. 4 The Cancer Council Australia and Australian Cancer Network SaNZGGW. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. 2008. 5Martin RC, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters KM. Is incisional biopsy of melanoma harmful? Am J Surg 2005; 190: 913–7. 6Pflugfelder A, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, Meier F, Garbe C. Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol 2010; 28: 316–8. 7Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch.Dermatol 2010; 146: 234–9. 8Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis S, Lens MB, Thompson JF. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009; 4: CD004835. 9Kenady DE, Brown BW, McBride CM. Excision of underlying fascia with a primary malignant melanoma: effect on recurrence and survival rates. Surgery 1982; 92: 615–8. 10McLeod M, Choudhary S, Giannakakis G, Nouri K. Surgical Treatments for Lentigo Maligna: A Review Dermatol Surg 2011; 10–4725. 11Stevenson O, Ahmed I. Lentigo maligna: prognosis and treatment options. Am J Clin Dermatol 2005; 6: 151–64. 12Mohrle M. [Micrographic controlled surgery (3D-histology) in cutaneous melanoma]. J Dtsch Dermatol Ges 2003; 1: 869–75. 13Loser C, Rompel R, Breuninger H, Mohrle M, Hafner HM, Kunte C, Hassel J, Hohenleutner U, Podda M, Sebastian G, Hafner J, Konz B, Kaufmann R. Microscopically controlled surgery (MCS). J Dtsch Dermatol Ges 2010; 8: 920–5. 14Lichte V, Breuninger H, Metzler G, Haefner HM, Moehrle M. Acral lentiginous melanoma: conventional histology vs. three-dimensional histology. Br J Dermatol 2009; 160: 591–9. 15Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H. ìFunctionalî surgery in subungual melanoma. Dermatol Surg 2003; 29: 366–74. 16Moehrle M, Dietz K, Garbe C, Breuninger H. Conventional histology vs. three-dimensional histology in lentigo maligna melanoma. The British journal of dermatology 2006; 154: 453–9. 17Farshad A, Burg G, Panizzon R, Dummer R. A retrospective study of 150 patients with lentigo maligna and lentigo ≠maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol 2002; 146: 1042–6. 18Schmid-Wendtner MH, Brunner B, Konz B, Kaudewitz P, Wendtner CM, Peter RU, Plewig G, Volkenandt M. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. Journal of the American Academy of Dermatology 2000; 43: 477–82. 19Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. International journal of radiation oncology, biology, physics 1983; 9: 1019–21. 20Stevens G, Thompson JF, Firth I, OíBrien CJ, McCarthy WH, Quinn MJ. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 2000; 88: 88–94. 21Storper IS, Lee SP, Abemayor E, Juillard G. The role of radiation therapy in the treatment of head and neck cutaneous melanoma. Am J Otolaryngol 1993; 14: 426–31. 22Ang KK, Peters LJ, Weber RS, Morrison WH, Frankenthaler RA, Garden AS, Goepfert H, Ha CS, Byers RM. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. International journal of radiation oncology, biology, physics 1994; 30: 795–8. 23Foote MC, Burmeister B, Burmeister E, Bayley G, Smithers BM. Desmoplastic melanoma: the role of radiotherapy in improving local control. ANZ J Surg 2008; 78: 273–6. 24Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck 2003; 25: 423–8. 25Wasif N, Gray RJ, Pockaj BA. Desmoplastic melanoma – the step-child in the melanoma family? J Surg Oncol 2011; 103: 158–62. 26Sawyer A, McGoldrick RB, Mackey SP, Allan R, Powell B. Does staging computered tomography change management in thick malignant melanoma? J Plast Reconstr Aesthet Surg 2009; 62: 453–6. 27Yancovitz M, Finelt N, Warycha MA, Christos PJ, Mazumdar M, Shapiro RL, Pavlick AC, Osman I, Polsky D, Berman RS. Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma. Cancer 2007; 110: 1107–14. 28Vereecken P, Laporte M, Petein M, Steels E, Heenen M. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients. J Eur Acad Dermatol Venereol 2005; 19: 66–73. 29Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R, Cormier JN. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst 2011; 103: 129–42. 30Schlamann M, Loquai C, Goericke S, Forsting M, Wanke I. Cerebral MRI in neurological asymptomatic patients with ≠malignant melanoma. Rofo 2008; 180: 143–7. 31Fogarty GB, Tartaglia C. The utility of magnetic resonance imaging in the detection of brain metastases in the staging of cutaneous melanoma. Clin Oncol (R.Coll.Radiol) 2006; 18: 360–2. 32Wang TS, Johnson TM, Cascade PN, Redman BG, Sondak VK, Schwartz JL. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. J Am Acad Dermatol 2004; 51: 399–405. 33Hafner J, Schmid MH, Kempf W, Burg G, Kunzi W, Meuli-Simmen C, Neff P, Meyer V, Mihic D, Garzoli E, Jungius KP, Seifert B, Dummer R, Steinert H. Baseline staging in cutaneous malignant melanoma. Br J Dermatol 2004; 150: 677–86. 34Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients–monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002; 87: 151–7. 35Terhune MH, Swanson N, Johnson TM. Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol 1998; 134: 569–72. 36Tsao H, Feldman M, Fullerton JE, Sober AJ, Rosenthal D, Goggins W. Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival. Arch Dermatol 2004; 140: 67–70. 37Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 2004; 5: 673–80. 38Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21: 520–9. 39Ardizzoni A, Grimaldi A, Repetto L, Bruzzone M, Sertoli MR, Rosso R. Stage I-II melanoma: the value of metastatic work-up. Oncology 1987; 44: 87–9. 40Goerz G, Schulte-Beerbuhl R, Roder K, Schoppe WD, Munchhoff C, Jungblut RM. Malignant melanoma: which examinations are useful in staging and follow-up? Dtsch Med Wochenschr 1986; 111: 1230–3. 41Mocellin S, Zavagno G, Nitti D. The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis. Int J Cancer 2008; 123: 2370–6. 42Hofmann MA, Gussmann F, Fritsche A, Biesold S, Schicke B, Kuchler I, Voit C, Trefzer U. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma. Melanoma Res 2009; 19: 17–23. 43Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 2003; 97: 1737–45. 44Krahn G, Kaskel P, Sander S, Waizenhofer PJ, Wortmann S, Leiter U, Peter RU. S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase. Anticancer Res 2001; 21: 1311–6. 45Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W, Buettner R. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997; 57: 3149–53. 46Veit-Haibach P, Vogt FM, Jablonka R, Kuehl H, Bockisch A, Beyer T, Dahmen G, Rosenbaum S, Antoch G. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging 2009; 36: 910–8. 47Khansur T, Sanders J, Das SK. Evaluation of staging workup in malignant melanoma. Arch Surg 1989; 124: 847–9. 48Zartman GM, Thomas MR, Robinson WA. Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol 1987; 35: 163–4. 49Kersey PA, Iscoe NA, Gapski JA, Osoba D, From L, DeBoer G, Quirt IC. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma. Br J Surg 1985; 72: 614–7. 50Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis. J Clin Oncol 2011. 51Warycha MA, Zakrzewski J, Ni Q, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Osman I. Meta-analysis of sentinel lymph node positivity in thin melanoma (<or = 1 mm). Cancer 2009; 115: 869–79. 52Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma. Melanoma Res 2010; 20: 330–7. 53Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010; 116: 1535–44. 54Testori A, De Salvo GL, Montesco MC, Trifiro G, Mocellin S, Landi G, Macripo G, Carcoforo P, Ricotti G, Giudice G, Picciotto F, Donner D, Di Filippo F, Soteldo J, Casara D, Schiavon M, Vecchiato A, Pasquali S, Baldini F, Mazzarol G, Rossi CR, Italian M, I. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 2009; 16: 2018–27. 55Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307–17. 56McMasters KM, Wong SL, Edwards MJ, Ross MI, Chao C, Noyes RD, Viar V, Cerrito PB, Reintgen DS. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 2001; 130: 151–6. 57Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005; 12: 230–5. 58Socrier Y, Lauwers-Cances V, Lamant L, Garrido I, Lauwers F, Lopez R, Rochaix P, Chevreau C, Payoux P, Viraben R, Paul C, Meyer N. Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients. Br J Dermatol 2010; 162: 830–4. 59Kaur MR, Colloby PS, Martin-Clavijo A, Marsden JR. Melanoma histopathology reporting: are we complying with the National Minimum Dataset? J Clin Pathol 2007; 60: 1121–3. 60Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, Gur E, Skornick Y, Schneebaum S. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003; 44: 1413–20. 61Mar MV, Miller SA, Kim EE, Macapinlac HA. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol 2007; 35: 10–6. 62Dengel LT, More MJ, Judy PG, Petroni GR, Smolkin ME, Rehm PK, Majewski S, Williams MB, Slingluff CL, Jr. Intraoperative imaging guidance for sentinel node biopsy in melanoma ≠using a mobile gamma camera. Ann Surg 2010. 63Vidal-Sicart S, Paredes P, Zanon G, Pahisa J, Martinez-Roman S, Caparros X, Vilalta A, Rull R, Pons F. Added value of intraoperative real-time imaging in searches for difficult-to-locate sentinel nodes. J Nucl Med 2010; 51: 1219–25. 64Wendler T, Herrmann K, Schnelzer A, Lasser T, Traub J, ≠Kutter O, Ehlerding A, Scheidhauer K, Schuster T, Kiechle M, Schwaiger M, Navab N, Ziegler SI,
Referência(s)